Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
作者信息
Nuzzi G, Venturini I, De Gregorio M, Arsenio L, Maraini G
机构信息
Institute of Ophthalmology, University of Parma, Italy.
出版信息
Acta Ophthalmol Scand. 1997 Feb;75(1):41-3. doi: 10.1111/j.1600-0420.1997.tb00247.x.
Abstract
Vitreous fluorophotometry was used to investigate the effect of Bendazac lysine on the blood retinal barrier in 12 insulin-dependent diabetics with mild background retinopathy. The study was a randomized, double blind, cross-over trial, drug versus Placebo. Each treatment period was of 4 months. The vitreous penetration coefficient was reduced by 21% (95% c.i. 12, 30; p = 0.001) by treatment with respect to Placebo.
摘要
Zotero 插件